TRIBUNNEWSMAKER.COM – Experts from the Oxford Vaccine Group said, vaccine will reduce the impact Covid-19 from a serious illness to just a cold.
Prof Andrew Pollard told the British MP that he was sure vaccine recently introduced will have a major impact on transmission Covid-19.
England rocked new variant Covid-19 which is more contagious.
There are concerns that this new variant may be resistant to vaccine.
Pollard answered this rumor by saying that vaccine Covid-19 which has been developed may reduce the risk of disease.
It could be that the new Covid-19 variant is not a serious disease but only in the form of a cold, as reported Arab News.
Pollard who has studied vaccine Covid-19 recently made his comments as the British government tried to convince the public of the efficacy of AstraZeneca.
Also read: Covid-19 Vaccination, Jokowi Affirms The Process Is Conducted In Clusters, Not Individuals
The government is trying to be, as a study finds it seems vaccine AstraZeneca is not very effective for new variant Covid-19.
Launch The Sun, Pollard says, though Covid-19 new variants will continue to exist, it doesn’t matter if vaccine now can reduce the intensity of hospitalization.
So far more than 12.6 million people have had their first dose vaccine made by Oxford, AstraZeneca and Pfizer.
–